1. Home
  2. MNKD vs QCRH Comparison

MNKD vs QCRH Comparison

Compare MNKD & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • QCRH
  • Stock Information
  • Founded
  • MNKD 1991
  • QCRH 1993
  • Country
  • MNKD United States
  • QCRH United States
  • Employees
  • MNKD N/A
  • QCRH N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • QCRH Major Banks
  • Sector
  • MNKD Health Care
  • QCRH Finance
  • Exchange
  • MNKD Nasdaq
  • QCRH Nasdaq
  • Market Cap
  • MNKD 1.4B
  • QCRH 1.1B
  • IPO Year
  • MNKD 2004
  • QCRH 1993
  • Fundamental
  • Price
  • MNKD $4.56
  • QCRH $67.06
  • Analyst Decision
  • MNKD Buy
  • QCRH Buy
  • Analyst Count
  • MNKD 6
  • QCRH 3
  • Target Price
  • MNKD $8.92
  • QCRH $86.67
  • AVG Volume (30 Days)
  • MNKD 1.5M
  • QCRH 91.1K
  • Earning Date
  • MNKD 05-08-2025
  • QCRH 04-22-2025
  • Dividend Yield
  • MNKD N/A
  • QCRH 0.36%
  • EPS Growth
  • MNKD 215.86
  • QCRH N/A
  • EPS
  • MNKD 0.10
  • QCRH 6.65
  • Revenue
  • MNKD $297,595,000.00
  • QCRH $324,275,000.00
  • Revenue This Year
  • MNKD $14.23
  • QCRH N/A
  • Revenue Next Year
  • MNKD $14.56
  • QCRH $15.85
  • P/E Ratio
  • MNKD $46.04
  • QCRH $10.01
  • Revenue Growth
  • MNKD 32.50
  • QCRH N/A
  • 52 Week Low
  • MNKD $4.17
  • QCRH $54.75
  • 52 Week High
  • MNKD $7.63
  • QCRH $96.08
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.80
  • QCRH 50.57
  • Support Level
  • MNKD $4.42
  • QCRH $64.64
  • Resistance Level
  • MNKD $5.05
  • QCRH $67.00
  • Average True Range (ATR)
  • MNKD 0.18
  • QCRH 1.82
  • MACD
  • MNKD 0.00
  • QCRH 0.48
  • Stochastic Oscillator
  • MNKD 20.59
  • QCRH 49.42

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About QCRH QCR Holdings Inc.

QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely QCBT, CRBT, CSB, and GB. It generates revenue in the form of interest.

Share on Social Networks: